Preimplantation testing for chromosome aneuploidy

Abstract

Around 50% of cleavage stage human embryos obtained by in vitro fertilisation (IVF) have an abnormal number of chromosomes. Aneuploidy testing has been introduced at some IVF centres with the aim of identifying and removing abnormal embryos and increasing pregnancy success rates. Randomised controlled trials have indicated that pregnancy and live birth rates are lower for women undergoing aneuploidy testing. Learning objectives: To understand the nature and frequency of chromosome abnormalities in cleavage stage human embryos. To understand the rationale underlying aneuploidy testing. To understand the results of research on aneuploidy testing. Ethical issues: Should aneuploidy testing be offered, when randomised trials indicate either that it has no effect or that it results in fewer ongoing pregnancies and live births? Please cite this article as: Ogilvie CM. Preimplantation testing for chromosome aneuploidy. The Obstetrician & Gynaecologist 2008;10:88–92.